-
FDA Approves Genentech Skin Cancer Drug
The Food and Drug Administration today approved the drug vismodegib to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug, marketed under the brand name Erivedge by Genentech in South San Francisco, is intended for use in patients with locally advanced basal cell cancer who are not candidates…
-
Nanotech Paint Devised to Monitor for Structural Damage
Researcher engineers at University of Strathclyde in Glasgow, U.K. have developed a type of paint that can help detect early signs of structural damage in bridges or buildings. Because this “smart paint” can be applied like any other paint and requires little maintenance, it costs a small fraction of traditional instrument-based sensors. Strathclyde civil engineering…
-
Venture Investment for European Companies Drops in 2011
Venture capital declined 14 percent and number of deals dropped 19 percent for European companies in 2011 compared to 2010, with €4.4 billion ($US 5.8 billion) going into 1,012 deals. Industries based on scientific discoveries were among those suffering double-digit percentage declines from the previous year. Dow Jones VentureSource that compiled the data says it…
-
Knee Replacement Maker Lands $89M Series E Financing
ConforMIS Inc. in Burlington, Massachusetts, a developer of customized knee-replacement implant technology, has raised $89 million in a series E round of funding, the fifth investment cycle after start up. The privately held company says the investments were made by private equity funds, led by AGC Equity Partners and Axel Johnson Inc., along with government…
-
FDA Approves Pfizer Drug for Advanced Kidney Cancer
The Food and Drug Administration today approved the drug axitinib to treat patients with renal cell carcinoma, a form of advanced kidney cancer, who have not responded to another drug for this type of cancer. The drug is made by Pfizer Inc. in New York and marketed under the brand name Inlyta. Renal cell carcinoma…
-
VC Company, Harvard Start Seed-Stage Fund
The Experiment Fund, a joint venture of Harvard University’s engineering school and venture capital company New Enterprise Associates (NEA), opened today in Cambridge, Massachusetts. The fund plans to support technology-based student start-ups in Cambridge and companies begun elsewhere by former students. The venture expects to support companies working in information technologies, health care, and energy.…
-
Columbia Joins Coulter Biomedical Engineering Partnership
Columbia University in New York and the Wallace H. Coulter Foundation in Miami will establish the Columbia-Coulter Translational Research Partnership, part of a network of biomedical engineering and translational research institutions in the U.S. The program is expected devote $5 million in funding over five years, with two-thirds of the funds from the Coulter Foundation,…
-
Medical Sensor Powered by Music Vibrations Developed
Engineers at Purdue University in Indiana have developed a miniature medical sensor that can be powered by vibrations from music played nearby, with the deep bass of rap music found most effective. The research conducted in the lab of Babak Ziaie, professor of electrical and computer engineering and biomedical engineering, will be presented at the…
-
NIH Trials to Assess Emergency Cardiac Arrest Treatments
NIH’s National Heart, Lung, and Blood Institute has begun two clinical trials to evaluate treatments for out-of-hospital cardiac arrest: – A comparison of continuous chest compressions (CCC) combined with pause-free rescue breathing, to standard cardiopulmonary resuscitation (CPR) that includes a combination of chest compressions and pauses for rescue breathing, and – Treatment with the drug…
-
$250K Challenge Seeks Post-Hospital Care Ideas
Janssen Healthcare Innovation, a unit of pharmaceutical company Johnson & Johnson in San Diego, is offering a challenge with a total of $250,000 in awards for technology solutions to improve the care for patients discharged from the hospital. The Janssen Connected Care Challenge was announced today by Kimberly Park, a Janssen Healthcare Innovation partner, at the…